Report Detail

Pharma & Healthcare Global Rifaximin Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

  • RnM2806582
  • |
  • 24 January, 2019
  • |
  • Global
  • |
  • 101 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Rifaximin, sold under the trade name Xifaxan among others, is an antibiotic used to treat traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. It has poor absorption when taken by mouth.

Scope of the Report:
The global Rifaximin market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rifaximin.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Rifaximin market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rifaximin market by product type and applications/end industries.

Market Segment by Companies, this report covers
Salix Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
200 mg Tablets
550 mg Tablets

Market Segment by Applications, can be divided into
Hospital
Drug store


Table of Contents

    1 Rifaximin Market Overview

    • 1.1 Product Overview and Scope of Rifaximin
    • 1.2 Classification of Rifaximin by Types
      • 1.2.1 Global Rifaximin Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Rifaximin Revenue Market Share by Types in 2018
      • 1.2.3 200 mg Tablets
      • 1.2.4 550 mg Tablets
    • 1.3 Global Rifaximin Market by Application
      • 1.3.1 Global Rifaximin Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospital
      • 1.3.3 Drug store
    • 1.4 Global Rifaximin Market by Regions
      • 1.4.1 Global Rifaximin Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Rifaximin Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Rifaximin Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rifaximin Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Rifaximin Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rifaximin Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Rifaximin (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Salix Pharmaceuticals
      • 2.1.1 Business Overview
      • 2.1.2 Rifaximin Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Salix Pharmaceuticals Rifaximin Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Rifaximin Market Competition, by Players

    • 3.1 Global Rifaximin Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Rifaximin Players Market Share
      • 3.2.2 Top 10 Rifaximin Players Market Share
    • 3.3 Market Competition Trend

    4 Global Rifaximin Market Size by Regions

    • 4.1 Global Rifaximin Revenue and Market Share by Regions
    • 4.2 North America Rifaximin Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Rifaximin Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Rifaximin Revenue and Growth Rate (2014-2019)
    • 4.5 South America Rifaximin Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Rifaximin Revenue and Growth Rate (2014-2019)

    5 North America Rifaximin Revenue by Countries

    • 5.1 North America Rifaximin Revenue by Countries (2014-2019)
    • 5.2 USA Rifaximin Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Rifaximin Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Rifaximin Revenue and Growth Rate (2014-2019)

    6 Europe Rifaximin Revenue by Countries

    • 6.1 Europe Rifaximin Revenue by Countries (2014-2019)
    • 6.2 Germany Rifaximin Revenue and Growth Rate (2014-2019)
    • 6.3 UK Rifaximin Revenue and Growth Rate (2014-2019)
    • 6.4 France Rifaximin Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Rifaximin Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Rifaximin Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Rifaximin Revenue by Countries

    • 7.1 Asia-Pacific Rifaximin Revenue by Countries (2014-2019)
    • 7.2 China Rifaximin Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Rifaximin Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Rifaximin Revenue and Growth Rate (2014-2019)
    • 7.5 India Rifaximin Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Rifaximin Revenue and Growth Rate (2014-2019)

    8 South America Rifaximin Revenue by Countries

    • 8.1 South America Rifaximin Revenue by Countries (2014-2019)
    • 8.2 Brazil Rifaximin Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Rifaximin Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Rifaximin Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Rifaximin by Countries

    • 9.1 Middle East and Africa Rifaximin Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Rifaximin Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Rifaximin Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Rifaximin Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Rifaximin Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Rifaximin Revenue and Growth Rate (2014-2019)

    10 Global Rifaximin Market Segment by Type

    • 10.1 Global Rifaximin Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Rifaximin Market Forecast by Type (2019-2024)
    • 10.3 200 mg Tablets Revenue Growth Rate (2014-2024)
    • 10.4 550 mg Tablets Revenue Growth Rate (2014-2024)

    11 Global Rifaximin Market Segment by Application

    • 11.1 Global Rifaximin Revenue Market Share by Application (2014-2019)
    • 11.2 Rifaximin Market Forecast by Application (2019-2024)
    • 11.3 Hospital Revenue Growth (2014-2019)
    • 11.4 Drug store Revenue Growth (2014-2019)

    12 Global Rifaximin Market Size Forecast (2019-2024)

    • 12.1 Global Rifaximin Market Size Forecast (2019-2024)
    • 12.2 Global Rifaximin Market Forecast by Regions (2019-2024)
    • 12.3 North America Rifaximin Revenue Market Forecast (2019-2024)
    • 12.4 Europe Rifaximin Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Rifaximin Revenue Market Forecast (2019-2024)
    • 12.6 South America Rifaximin Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Rifaximin Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Rifaximin . Industry analysis & Market Report on Rifaximin is a syndicated market report, published as Global Rifaximin Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Rifaximin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,721.36
      4,082.04
      5,442.72
      3,198.12
      4,797.18
      6,396.24
      542,218.80
      813,328.20
      1,084,437.60
      290,580.00
      435,870.00
      581,160.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report